Latest News
Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market
Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances second phase of clinical program
Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant
Patent strengthens competitive position in European drug screening market and reinforces Company’s European intellectual property protection NEW YORK, March 26,
Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry
Successful delivery in partnership with Syrma Johari validates manufacturing scale, strengthens commercial readiness, and supports planned U.S. market entry in